NF1 is strongly affected by the treatment of BRAF-sensitive melanoma cell lines with BRAF inhibitors, and NF1 knockdown abrogated the growth inhibitory effects elicited by BRAF inhibition [89]. Here, NF1 is linked to melanoma.